N.H. Admin. Code § Opt 402.01

Current through Register No. 50, December 12, 2024
Section Opt 402.01 - Continuing Education Required
(a) All Therapeutic Pharmaceutical Agents (TPA) certified licensed optometrists shall complete a minimum of 50 credit hours of approved continuing education (CE) requirements every year, at least 20 credit hours of which shall be in Class I, and the remainder of which shall be Class II. When accumulating Class I credit hours, 8 of the 20 hours may be alternative CE, as defined in Opt 402.04(a)(2), and the balance shall come from formal CE, as defined in Opt 402.04(a)(1). An optometrist with prescriptive authority to treat glaucoma shall complete 10 of the required hours in glaucoma specific education, a minimum of 7 hours of which shall be in Class I, and the remainder in Class II.
(b) Class I credit hours shall be accumulated through participation in formal courses and alternative CE that meet the requirements of Opt 402.04.
(c) Class II credit hours shall be earned through independent study documented as required by Opt 402.04.
(d) Licensees who possesses a United States Drug Enforcement Administration (DEA) number shall complete 3 hours of online continuing education or pass an online examination in the area of pain management, addiction disorder, or combination of both. The 3 hours shall not count toward the 8 alternative CE requirements described in (a) above.

N.H. Admin. Code § Opt 402.01

(See Revision Note at part heading for Opt 100) #5839, eff 6-17-94, EXPIRED: 6-17-00

New. #7370, INTERIM, eff 9-30-00, EXPIRED: 3-29-01

New. #7670, eff 4-4-02; amd by #7889, eff 5-20-03; amd by #9342, eff 12-9-08

Amended by Volume XXXVII Number 10, Filed March 9, 2017, Proposed by #12108, Effective 2/21/2017, Expires 8/20/2017.
Amended by Volume XXXVII Number 41, Filed October 12, 2017, Proposed by #12383, Effective 9/16/2017, Expires 9/16/2027.
Amended by Volume XXXIX Number 24, Filed June 13, 2019, Proposed by #12778, Effective 5/14/2019, Expires 5/14/2029.
Amended by Number 6, Filed February 8, 2024, Proposed by #13848, Effective 3/9/2024, Expires 3/9/2034